Form 4: HeartBeam CFO Granted 53,104 Stock Options

HeartBeam's CFO, Tim Cruickshank, was granted 53,104 stock options with an exercise price of $1.45, vesting in two tranches by June 2026.

Summary

• Tim Cruickshank, the Chief Financial Officer (CFO) of HeartBeam, Inc. (BEAT), was granted 53,104 stock options.
• The options have an exercise price of $1.45 per share.
• The grant date for these options was February 9, 2026.
• The options were issued from the Company's 2022 Equity Incentive Plan.
• One half of the total shares (26,552) subject to the option will vest on March 31, 2026, which is the three-month anniversary of the vesting commencement date of January 1, 2026.
• The remaining half of the shares (26,552) will vest on June 30, 2026, the six-month anniversary of the vesting commencement date.
• The options have an expiration date of January 1, 2036.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive development, primarily due to the alignment of management incentives with shareholder interests. It is a routine compensation event and not indicative of significant operational or financial news.

Positives

• The grant of stock options to the CFO aligns management's financial interests with those of shareholders, incentivizing long-term company performance.
• The options are issued under the company's established 2022 Equity Incentive Plan, indicating a structured approach to executive compensation.

Future Outlook

The vesting schedule for the options indicates a future alignment of the CFO's equity ownership with the company's performance over the next six months, with full vesting expected by June 30, 2026.

Industry Context

StockSavvy.ai notes that granting stock options is a standard practice in executive compensation across various industries. It serves to attract, retain, and motivate key personnel by providing them with a direct stake in the company's long-term success and share price appreciation.

Comparison to Industry Standards

• Option grants are a common component of executive compensation packages across the technology and healthcare sectors, aiming to align management incentives with shareholder value.
• Without specific peer group data on compensation structures or the CFO's overall compensation package, a direct comparison of the size or terms of this specific grant to industry benchmarks is not feasible from this filing alone.

Corporate Governance

Stakeholder Impact

• Shareholders: The option grant aims to align the CFO's interests with shareholders, potentially leading to better long-term performance and value creation.
• Employees: While specific to the CFO, such grants are part of a broader compensation strategy that can influence overall employee morale and retention, particularly for key executives.

Next Steps

• One half of the granted options are scheduled to vest on March 31, 2026.
• The remaining half of the granted options are scheduled to vest on June 30, 2026.

Key Dates

Keywords

HeartBeam, BEAT, stock options, CFO, equity incentive plan, insider transaction, Form 4, executive compensation